| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $101.59B | - | |
| CEO | 515.2K | $567.75M | - | |
| VP | 137.5K | $151.52M | - | |
| Dir | 75.1K | $82.77M | - | |
| Dir | 55.5K | $61.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 41,857 | $329.05 | $13,772,836.57 | - | -5.7% | +42.8% | |
| Jun 24, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 215,000 | $324.31 | $69,726,323.87 | - | -4.2% | +41.8% | |
| Jun 23, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $311.05 | $63,764,750.24 | - | -4.9% | +47.6% | |
| Jun 22, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $306.84 | $64,435,610.54 | - | -1.3% | +50.1% | |
| Jun 1, 2022 | Zakrowski Donald A | Chief Accounting Officer | Sell | 1,000 | $313.44 | $313,440.00 | -13.7% | -1.0% | +41.2% | |
| May 27, 2022 | Lilly Endowment Inc | 10% Owner | Sell | 87,665 | $317.63 | $27,844,685.73 | - | +0.2% | +32.4% |